COSMOS CHOUZAI PharmacyLtd Past Earnings Performance
Past criteria checks 2/6
COSMOS CHOUZAI PharmacyLtd has been growing earnings at an average annual rate of 42.1%, while the Consumer Retailing industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 6.6% per year. COSMOS CHOUZAI PharmacyLtd's return on equity is 10.1%, and it has net margins of 0.4%.
Key information
42.1%
Earnings growth rate
28.2%
EPS growth rate
| Consumer Retailing Industry Growth | 7.8% |
| Revenue growth rate | 6.6% |
| Return on equity | 10.1% |
| Net Margin | 0.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How COSMOS CHOUZAI PharmacyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 6,187 | 27 | 2,425 | 0 |
| 31 Mar 23 | 5,804 | 19 | 2,457 | 0 |
Quality Earnings: 309A has a large one-off loss of ¥122.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 309A's current net profit margins (0.4%) are higher than last year (0.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if 309A's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare 309A's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: 309A earnings growth over the past year (42.1%) exceeded the Consumer Retailing industry 11.1%.
Return on Equity
High ROE: 309A's Return on Equity (10.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/11 04:40 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
COSMOS CHOUZAI Pharmacy Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|